Tarsus Pharmaceuticals, Inc.

TARSNASDAQHealthcare● Active

$59.64

+$0.36(+0.61%)

Market Cap$2.6B

P/E Ratio—

52W High$85.25

52W Low$38.51

Avg Volume623K

Open$59.43

Beta0.51

Employees Ownership Insider Trades

Tarsus Pharmaceuticals, Inc. (TARS) Number of Employees – History & Annual Headcount

Annual SEC headcount, year-over-year change, and per-employee efficiency — chart and full history below.

SEC EDGAR · FMP · TARS · as of Feb 23, 2026

Latest filing snapshot

370

+47+14.55%vs prior year

Tarsus Pharmaceuticals, Inc. (TARS) employee data is sourced from the annual SEC 10-K filing. As of 2025, full-time employees only. Global consolidated headcount. View SEC filing ↗

SEC 10-K·Period end: 2025-12-31·Full-time · Global

Total Employees

370

Change (1Y)

+47

Growth % (1Y)

+14.55%

Revenue / Employee

$1.22M

Net Income / Employee

$-179.5K

Market Cap

$2.6B

TARS Employee Count

2020 – 2025 · Annual · SEC filing

Source: SEC annual filings · Hover bar to view year data · Click to view original filing

Employees History

Filing Date	Period End	Employees	Change (1Y)	Growth (1Y)
2026-02-23	2025-12-31	370	+47	+14.55%
2025-02-25	2024-12-31	323	+79	+32.38%
2024-02-27	2023-12-31	244	+157	+180.46%
2023-03-17	2022-12-31	87	+41	+89.13%
2022-03-14	2021-12-31	46	+26	+130.00%
2021-03-31	2020-12-31	20	—	—

▸ Source: SEC Annual Reports (Form 10-K / 20-F). Employee counts as of fiscal year end. Click the ↗ icon at the end of a row to open the original SEC filing in a new tab.

Related Companies — Employee Count

Biotechnology

#SymbolCompanyEmployeesMkt Cap

ADPT

Adaptive Biotechnologies Corporation

619$2.7B #2

AAPG

Ascentage Pharma Group International

567$1.6B #3

TARS

Tarsus Pharmaceuticals, Inc.YOU

370$2.6B #4

ARQT

Arcutis Biotherapeutics, Inc.

342$2.7B #5

CGON

CG Oncology, Inc. Common stock

Source: /stock-peers + /profile.fullTimeEmployees · Click row → /employees · Sorted by headcount · TARS peer comparison

About TARS employees

TARS Employees · Headcount

Tarsus Pharmaceuticals, Inc. (TARS) employee data is sourced from the annual SEC 10-K filing. As of 2025, Tarsus Pharmaceuticals, Inc. had 370 full-time employees globally. Full-time employees only. Global consolidated headcount.

Tarsus Pharmaceuticals, Inc. employs 370 full-time employees as of the latest filing within the Biotechnology industry. Revenue per employee stands at $1.22M, reflecting the company's operational efficiency.

Tarsus Pharmaceuticals, Inc.'s workforce increased by 47 (14.55%) in 2025 compared to the prior fiscal year. The historical trend reflects the company's expansion and contraction cycles.

Tarsus Pharmaceuticals, Inc.'s revenue per employee of $1.22M positions it among the notable performers in the Biotechnology sector for operational efficiency.

Revenue Financial statements Net income SEC filings Price history Forecast & ratings Ownership Earnings

Frequently Asked Questions

TARS Employees · 5 questions

As of the latest SEC 10-K filing (2025), Tarsus Pharmaceuticals, Inc. had 370 full-time employees globally. This figure is sourced from the company's mandatory annual disclosure to the SEC.

Tarsus Pharmaceuticals, Inc. employee counthow many employees does Tarsus Pharmaceuticals, Inc. haveTARS total employees 2025

▸ Data source: FMP /historical-employee-count · SEC EDGAR annual filings · As reported · Global consolidated headcount · As of 2026-02-23